PUBLISHER: TechNavio | PRODUCT CODE: 2125878
PUBLISHER: TechNavio | PRODUCT CODE: 2125878
Global Neurology Devices Market 2026-2030
The global neurology devices market is forecasted to grow by USD 8942.9 mn during 2025-2030, accelerating at a CAGR of 8.5% during the forecast period. The report on the global neurology devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of neurodegenerative disorders driving mass demand for advanced therapeutic technologies, accelerating clinical shift toward minimally invasive neurovascular procedures and advanced ischemic stroke interventions, continuous technological advancements in closed loop neuromodulation platforms and ai diagnostic software integration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 8% |
| CAGR | 8.5% |
| Incremental Value | $8942.9 mn |
Technavio's global neurology devices market is segmented as below:
By End-User
- Hospitals
- ASCs
- Others
By Product
- Neurostimulation devices
- Interventional neurology devices
- Neurosurgery devices
- Cerevrospinal fluid management devices
- Others
By Application
- Ischemic strokes
- Cerebral aneurysms
- Carotid artery stenosis
- Fistulas
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the widespread industry transition toward adaptive closed loop neurostimulation and personalized brain signal analytics as one of the prime reasons driving the global neurology devices market growth during the next few years. Also, strategic integration of high density cortical sensing interfaces and non invasive neuro-diagnostic tools and rapid commercialization of focused ultrasound systems for non invasive lesioning and ablation procedures will lead to sizable demand in the market.
The report on the global neurology devices market covers the following areas:
- Global neurology devices market sizing
- Global neurology devices market forecast
- Global neurology devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global neurology devices market vendors that include Abbott Laboratories, B.Braun SE, Boston Scientific Corp., Brainlab AG, electroCore Inc., GE HealthCare Technologies, Integra LifeSciences Corp., Johnson and Johnson, LivaNova PLC, Medtronic Plc, MicroPort Scientific Corp., Natus Medical Inc., NeuroPace Inc., Nexstim Plc, Nihon Kohden Corp., Penumbra Inc., Siemens Healthineers AG, Stryker Corp., Terumo Corp., Zimmer Biomet Holdings Inc.. Also, the global neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Neurology Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Neurology Devices Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global neurology devices market
- 6.2 Impact of geopolitical conflicts on global neurology devices market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2025-2030
- 8.4 ASCs - Market size and forecast 2025-2030
- 8.5 Others - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Neurostimulation devices - Market size and forecast 2025-2030
- 9.4 Interventional neurology devices - Market size and forecast 2025-2030
- 9.5 Neurosurgery devices - Market size and forecast 2025-2030
- 9.6 Cerevrospinal fluid management devices - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Ischemic strokes - Market size and forecast 2025-2030
- 10.4 Cerebral aneurysms - Market size and forecast 2025-2030
- 10.5 Carotid artery stenosis - Market size and forecast 2025-2030
- 10.6 Fistulas - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 Turkey - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global prevalence of neurodegenerative disorders driving mass demand for advanced therapeutic technologies
- Accelerating clinical shift toward minimally invasive neurovascular procedures and advanced ischemic stroke interventions
- Continuous technological advancements in closed loop neuromodulation platforms and ai diagnostic software integration
- 13.2 Market challenges
- Severe regulatory hurdles and extended verification timelines for complex invasive neuromodulation systems
- Substantial financial pressures and unfavorable healthcare reimbursement frameworks across global markets
- Heightened cybersecurity vulnerabilities and data privacy risks in modern connected neurological implants
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Widespread industry transition toward adaptive closed loop neurostimulation and personalized brain signal analytics
- Strategic integration of high density cortical sensing interfaces and non invasive neuro-diagnostic tools
- Rapid commercialization of focused ultrasound systems for non invasive lesioning and ablation procedures
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- SWOT
- 15.6 Boston Scientific Corp.
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
- 15.7 GE HealthCare Technologies
- GE HealthCare Technologies - Overview
- GE HealthCare Technologies - Business segments
- GE HealthCare Technologies - Key news
- GE HealthCare Technologies - Key offerings
- GE HealthCare Technologies - Segment focus
- SWOT
- 15.8 Integra LifeSciences Corp.
- Integra LifeSciences Corp. - Overview
- Integra LifeSciences Corp. - Business segments
- Integra LifeSciences Corp. - Key offerings
- Integra LifeSciences Corp. - Segment focus
- SWOT
- 15.9 Johnson and Johnson
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- 15.10 LivaNova PLC
- LivaNova PLC - Overview
- LivaNova PLC - Business segments
- LivaNova PLC - Key offerings
- LivaNova PLC - Segment focus
- SWOT
- 15.11 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.12 MicroPort Scientific Corp.
- MicroPort Scientific Corp. - Overview
- MicroPort Scientific Corp. - Business segments
- MicroPort Scientific Corp. - Key offerings
- MicroPort Scientific Corp. - Segment focus
- SWOT
- 15.13 Nihon Kohden Corp.
- Nihon Kohden Corp. - Overview
- Nihon Kohden Corp. - Business segments
- Nihon Kohden Corp. - Key offerings
- Nihon Kohden Corp. - Segment focus
- SWOT
- 15.14 Penumbra Inc.
- Penumbra Inc. - Overview
- Penumbra Inc. - Product / Service
- Penumbra Inc. - Key offerings
- SWOT
- 15.15 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.16 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
- 15.18 Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key news
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
